Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04223245 · ClinicalTrials.gov registry record · NA
A Home Program Using Multimodal Sensory Feedback for People With Parkinson Disease
A NA study of Parkinson Disease, sponsored by Regis University.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT04223245: Completed NA study of Parkinson Disease, sponsored by Regis University.
NCT04223245 is a NA study of Parkinson Disease that has completed, run by Regis University. The registered enrollment target is 26 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04223245, a NA study of Parkinson Disease, has completed, sponsored by Regis University.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
People with Parkinson Disease (PWPD) have significant problems with velocity, safety and dual tasking during walking that may be secondary to poor automaticity. Sensory functions, especially visual dependence and proprioceptive integration are critical for efficient walking and are often impaired. This home program compares the use of multimodal sensory feedback during stepping and balance exercises in PWPD to a group without the sensory feedback performing the same basic exercises.
Primary Outcome
temporal and spacial components of gait measured with Gaitrite Mat
Conditions Studied
Interventions
- BEHAVIORAL Exercise only
- BEHAVIORAL exercise+multi-modal sensory feedback (MMSF)
Study Locations (1)
Colorado
- Regis University - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2017-06-29 |
| Est. Completion | 2019-03-08 |
| Phase | NA |
What the finished NCT04223245 record still lists
NCT04223245 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which Exercise only is the first listed.
NCT04223245 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT04223245 about?
NCT04223245 is a clinical study titled "A Home Program Using Multimodal Sensory Feedback for People With Parkinson Disease". People with Parkinson Disease (PWPD) have significant problems with velocity, safety and dual tasking during walking that may be secondary to poor automaticity. Sensory functions, especially visual dependence and proprioceptive integration are critical for efficient walking and are often impaired. T...
What is the current status of trial NCT04223245?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2017-06-29. Estimated completion is 2019-03-08.
What conditions does trial NCT04223245 study?
This clinical trial studies the following conditions: Parkinson Disease.
What interventions are being tested in trial NCT04223245?
The interventions under investigation include: Exercise only (BEHAVIORAL), exercise+multi-modal sensory feedback (MMSF) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04223245?
This trial is sponsored by Regis University, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04223245 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04223245's enrollment target sits among peer trials
26 223rd of 297 higher than 74 of 297 other Parkinson Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Neurophysiology of Reward Signaling in Parkinson's Disease
RECRUITING · NA
-
Balance Tele-Rehab in Parkinson's Disease Parkinson's Disease
RECRUITING · NA
-
Rock Steady Boxing: A Community Based In Person Class
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI